State Street’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
State Street's OCDX Position: Q2 2022 in Review
State Street sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 2,648,579 shares — an estimated $49.4M sold.
State Street first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $56.7M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.
- State Street reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
- State Street sold 2,648,579 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $49.4M.
- State Street first reported a position in Ortho Clinical Diagnostics Holdings in Q1 2021 and held it in 5 quarters.
- State Street's Ortho Clinical Diagnostics Holdings position peaked at $56.7M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.
Based on State Street's 13F filing for Q2 2022, filed 15 Aug 2022.